Chemoprevention of bladder cancer.
La Rochelle
Jeffrey
J
David Geffen School of Medicine at UCLA, Los Angeles, CA 90025-1738, USA.
Kamat
Ashish
A
Grossman
H Barton
HB
Pantuck
Allan
A
D014408:Biomarkers, Tumor / Q000378:metabolism; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D052246:Cyclooxygenase 2 Inhibitors / Q000627:therapeutic use*; D000518:Eflornithine / Q000627:therapeutic use; D006801:Humans; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000517:prevention & control*; D014815:Vitamins / Q000627:therapeutic use*
D014408:Biomarkers, Tumor; D052246:Cyclooxygenase 2 Inhibitors; D014815:Vitamins; D000518:Eflornithine